USD 0.99
(13.45%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 124.51 Million USD | 2671.84% |
2022 | 4.46 Million USD | -65.27% |
2021 | 12.85 Million USD | 4341.25% |
2020 | -303 Thousand USD | -350.41% |
2019 | 121 Thousand USD | -52.92% |
2018 | 257 Thousand USD | 0.0% |
2017 | 257 Thousand USD | 0.0% |
2016 | 257 Thousand USD | 0.0% |
2015 | 257 Thousand USD | 101.81% |
2014 | -14.19 Million USD | -2670.65% |
2013 | 552 Thousand USD | -77.68% |
2012 | 2.47 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 1.37 Million USD | 115.23% |
2024 Q2 | 736 Thousand USD | -46.39% |
2023 Q2 | 131.02 Million USD | 13095.17% |
2023 Q1 | 993 Thousand USD | -25.23% |
2023 FY | 123.7 Million USD | 2671.84% |
2023 Q4 | -9.01 Million USD | -752.39% |
2023 Q3 | 1.38 Million USD | -98.95% |
2022 Q3 | 1.36 Million USD | 16.03% |
2022 Q4 | 1.32 Million USD | -2.92% |
2022 Q1 | 588 Thousand USD | 36.74% |
2022 FY | 4.46 Million USD | -65.27% |
2022 Q2 | 1.17 Million USD | 100.51% |
2021 Q2 | -109 Thousand USD | -100.9% |
2021 Q1 | 12.05 Million USD | 0.0% |
2021 Q4 | 430 Thousand USD | 15.9% |
2021 Q3 | 371 Thousand USD | 440.37% |
2021 FY | 12.85 Million USD | 4341.25% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 FY | -303 Thousand USD | -350.41% |
2020 Q1 | - USD | 0.0% |
2019 FY | 121 Thousand USD | -52.92% |
2019 Q1 | 64 Thousand USD | 0.0% |
2019 Q3 | - USD | -100.0% |
2019 Q4 | - USD | 0.0% |
2019 Q2 | 57 Thousand USD | -10.94% |
2018 FY | 257 Thousand USD | 0.0% |
2018 Q4 | 64 Thousand USD | 0.0% |
2018 Q3 | 64 Thousand USD | 0.0% |
2018 Q2 | 64 Thousand USD | 0.0% |
2018 Q1 | 64 Thousand USD | 0.0% |
2017 Q1 | 64 Thousand USD | 0.0% |
2017 Q2 | 64 Thousand USD | 0.0% |
2017 Q3 | 64 Thousand USD | 0.0% |
2017 Q4 | 64 Thousand USD | 0.0% |
2017 FY | 257 Thousand USD | 0.0% |
2016 Q4 | 64 Thousand USD | 0.0% |
2016 Q1 | 64 Thousand USD | 102.02% |
2016 Q3 | 64 Thousand USD | 0.0% |
2016 Q2 | 64 Thousand USD | 0.0% |
2016 FY | 257 Thousand USD | 0.0% |
2015 Q2 | 64 Thousand USD | -3.03% |
2015 Q1 | 66 Thousand USD | -96.0% |
2015 FY | 257 Thousand USD | 101.81% |
2015 Q3 | 64 Thousand USD | 0.0% |
2015 Q4 | -3.16 Million USD | -5048.44% |
2014 FY | -14.19 Million USD | -2670.65% |
2014 Q2 | 462 Thousand USD | -37.99% |
2014 Q3 | 720 Thousand USD | 55.84% |
2014 Q4 | 1.65 Million USD | 129.31% |
2014 Q1 | 745 Thousand USD | 837.62% |
2013 Q3 | 177 Thousand USD | 203.51% |
2013 FY | 552 Thousand USD | -77.68% |
2013 Q4 | -101 Thousand USD | -157.06% |
2013 Q1 | 647 Thousand USD | 0.0% |
2013 Q2 | -171 Thousand USD | -126.43% |
2012 FY | 2.47 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Collegium Pharmaceutical, Inc. | 326.16 Million USD | 61.824% |
Embecta Corp. | 749.9 Million USD | 83.396% |
ANI Pharmaceuticals, Inc. | 305.3 Million USD | 59.215% |
Dynavax Technologies Corporation | 182.11 Million USD | 31.628% |
Esperion Therapeutics, Inc. | 73.06 Million USD | -70.415% |
Pacira BioSciences, Inc. | 490.3 Million USD | 74.604% |
PainReform Ltd. | -15 Thousand USD | 830213.333% |
Aquestive Therapeutics, Inc. | 29.75 Million USD | -318.516% |
Sunshine Biopharma, Inc. | 8.33 Million USD | -1393.158% |
China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -22377.169% |
Cosmos Health Inc. | 4.34 Million USD | -2762.743% |
Journey Medical Corporation | 52.52 Million USD | -137.08% |
Sunshine Biopharma, Inc. | 8.33 Million USD | -1393.158% |
Safety Shot Inc | -74.45 Thousand USD | 167333.437% |
Alpha Teknova, Inc. | 10.29 Million USD | -1109.373% |
Intra-Cellular Therapies, Inc. | 430.62 Million USD | 71.085% |
Bright Green Corporation | -237.01 Thousand USD | 52635.272% |
Procaps Group, S.A. | 239.56 Million USD | 48.025% |
Theratechnologies Inc. | 62.12 Million USD | -100.417% |
Harrow Health, Inc. | 90.55 Million USD | -37.507% |
Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -2524.173% |
Biofrontera Inc. | 16.62 Million USD | -648.884% |
DURECT Corporation | 6.83 Million USD | -1722.822% |
Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 76.226% |
Cronos Group Inc. | 6.99 Million USD | -1681.131% |
OptiNose, Inc. | 62.35 Million USD | -99.694% |
Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 71.775% |
Kala Pharmaceuticals, Inc. | -303 Thousand USD | 41194.719% |
RedHill Biopharma Ltd. | 3.05 Million USD | -3976.947% |
Organogenesis Holdings Inc. | 309.79 Million USD | 59.806% |
Guardion Health Sciences, Inc. | 5.39 Million USD | -2208.214% |
Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -271.849% |
Radius Health, Inc. | 307.71 Million USD | 59.534% |
Universe Pharmaceuticals INC | 10.07 Million USD | -1135.548% |
ProPhase Labs, Inc. | 16.23 Million USD | -666.778% |
Phibro Animal Health Corporation | 312.48 Million USD | 60.153% |
Procaps Group S.A. | 239.56 Million USD | 48.025% |
Alvotech | -69.42 Million USD | 279.362% |
TherapeuticsMD, Inc. | 1.3 Million USD | -9463.518% |
Viatris Inc. | 6.43 Billion USD | 98.066% |
Rockwell Medical, Inc. | 8.7 Million USD | -1330.572% |
Aytu BioPharma, Inc. | 54.58 Million USD | -128.112% |
SIGA Technologies, Inc. | 122.09 Million USD | -1.986% |
Tilray Brands, Inc. | 223.35 Million USD | 44.251% |
Lifecore Biomedical, Inc. | 41.85 Million USD | -197.532% |
Shineco, Inc. | 882.16 Thousand USD | -14014.885% |
PetIQ, Inc. | 252.74 Million USD | 50.733% |
Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 16800.51% |
Incannex Healthcare Limited | 12 Thousand USD | -1037541.667% |
Neurocrine Biosciences, Inc. | 1.84 Billion USD | 93.26% |
Alimera Sciences, Inc. | 61.17 Million USD | -103.559% |
Silver Spike Investment Corp. | 8.1 Million USD | -1436.754% |
Assertio Holdings, Inc. | 125.04 Million USD | 0.425% |
Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 1828275.011% |
Petros Pharmaceuticals, Inc. | 4.19 Million USD | -2870.938% |
Clever Leaves Holdings Inc. | 6.55 Million USD | -1799.283% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 5266.303% |
Avadel Pharmaceuticals plc | 27.11 Million USD | -359.184% |
Hempacco Co., Inc. | -1.21 Million USD | 10341.291% |
Talphera, Inc. | -4.89 Million USD | 2643.759% |
Alvotech | -69.42 Million USD | 279.362% |
Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 43.829% |
Lantheus Holdings, Inc. | 709.54 Million USD | 82.451% |
Currenc Group, Inc. | 17.35 Million USD | -617.417% |
Kamada Ltd. | 52.59 Million USD | -136.757% |
Indivior PLC | 907 Million USD | 86.272% |
Evoke Pharma, Inc. | 4.97 Million USD | -2400.969% |
Flora Growth Corp. | 17.73 Million USD | -601.979% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 5266.303% |
Evolus, Inc. | 140.52 Million USD | 11.392% |
HUTCHMED (China) Limited | 453.55 Million USD | 72.546% |
Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 63.8% |
Akanda Corp. | 111.44 Thousand USD | -111625.543% |